Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma.
Saved in:
| Title: | Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma. |
|---|---|
| Authors: | Grözinger M; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany., Schlanke M; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany.; Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany., Gröne J; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany.; Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany., Erdmann S; Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany, Heidelberg, Germany., Hajiyianni M; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Poos AM; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Thierjung H; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany., Mai EK; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; GMMG-Studygroup at Heidelberg University Hospital, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Sauer S; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Kaudewitz D; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Veelken K; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Michel CS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Frenking JH; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sester LS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Weber TF; Clinic for Diagnostic and Interventional Radiology (DIR), Heidelberg University Hospital, Heidelberg, Germany., Sedaghat S; Clinic for Diagnostic and Interventional Radiology (DIR), Heidelberg University Hospital, Heidelberg, Germany., Wennmann M; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany., Müller-Tidow C; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Schlemmer HP; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany., Delorme S; German Cancer Research Center (DKFZ), Division of Radiology, Heidelberg, Germany., Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Goldschmidt H; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; GMMG-Studygroup at Heidelberg University Hospital, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany., Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., John L; Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany. lukas.john@med.uni-heidelberg.de.; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. lukas.john@med.uni-heidelberg.de. |
| Source: | Leukemia [Leukemia] 2026 Feb; Vol. 40 (2), pp. 339-347. Date of Electronic Publication: 2025 Dec 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
